These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6779101)

  • 41. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunization with 3-oxododecanoyl-L-homoserine lactone-r-PcrV conjugate enhances survival of mice against lethal burn infections caused by Pseudomonas aeruginosa.
    Golpasha ID; Mousavi SF; Owlia P; Siadat SD; Irani S
    Bosn J Basic Med Sci; 2015 May; 15(2):15-24. PubMed ID: 26042508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Depression of contact sensitivity by Pseudomonas aeruginosa-induced suppressor cells which affect the induction phase of immune response.
    Garzelli C; Colizzi V; Campa M; Bozzi L; Falcone G
    Infect Immun; 1979 Oct; 26(1):4-11. PubMed ID: 159263
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Delayed hypersensitivity to Trypanosoma cruzi in mice: specific suppressor cells in chronic infection.
    Scott MT
    Immunology; 1981 Oct; 44(2):409-17. PubMed ID: 6457792
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibody response to outer-membrane antigens of Pseudomonas aeruginosa in human burn wound infection.
    Ward KH; Anwar H; Brown RW; Wale J; Gowar J
    J Med Microbiol; 1988 Nov; 27(3):179-90. PubMed ID: 3143013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Establishment and comparison of delayed-type hypersensitivity models in the B₆C₃F₁ mouse.
    Smith MJ; White KL
    J Immunotoxicol; 2010; 7(4):308-17. PubMed ID: 20825253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of Langerhans cells in Pseudomonas aeruginosa infection.
    Hazlett LD; McClellan SA; Rudner XL; Barrett RP
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):189-97. PubMed ID: 11773031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapy of established experimental Pseudomonas aeruginosa infections with oral ciprofloxacin and five human monoclonal antibodies against lipopolysaccharide antigens.
    Collins MS; Ladehoff D; Mehton NS
    Antibiot Chemother (1971); 1991; 44():185-95. PubMed ID: 1801636
    [No Abstract]   [Full Text] [Related]  

  • 49. Cell-mediated and humoral immune response to non-viable Mycoplasma pulmonis in mice enhanced by cross-linked ricin.
    Kishima M; Kuniyasu C; Eguchi M; Yamamoto M; Imamura E
    Vet Microbiol; 1987 Jun; 14(2):145-56. PubMed ID: 3660582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-PcrV IgY antibodies protect against Pseudomonas aeruginosa infection in both acute pneumonia and burn wound models.
    Ranjbar M; Behrouz B; Norouzi F; Mousavi Gargari SL
    Mol Immunol; 2019 Dec; 116():98-105. PubMed ID: 31634816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunoglobulin allotypes and IgG subclass antibody response to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients.
    Pressler T; Pandey JP; Espersen F; Pedersen SS; Fomsgaard A; Koch C; Høiby N
    Clin Exp Immunol; 1992 Nov; 90(2):209-14. PubMed ID: 1424275
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Common protective antigen (OEP) of Pseudomonas aeruginosa.
    Abe C; Shionoya H; Hirao Y; Okada K; Homma JY
    Jpn J Exp Med; 1975 Oct; 45(5):355-9. PubMed ID: 817054
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The in vitro induction of delayed-type hypersensitivity to allo-antigens of the mouse.
    Barrington-Leigh J
    J Immunol Methods; 1984 Apr; 69(2):149-63. PubMed ID: 6232322
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Experimental infection of immunized mice homologous and heterologous serotypes with Pseudomonas aeruginosa].
    Vidal G; Mynard MC
    Ann Inst Pasteur (Paris); 1972 Jun; 122(6):1129-35. PubMed ID: 4627762
    [No Abstract]   [Full Text] [Related]  

  • 55. Cellular immune response to sheep erythrocytes: interrelationship between proliferation of popliteal lymph node cells and footpad swelling.
    Papadimitriou C; Hahn H; Näher H; Kaufmann SH
    Immunobiology; 1983 May; 164(5):361-9. PubMed ID: 6603413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa.
    Collins MS; Ladehoff DK; Mehton NS; Noonan JS
    FEMS Microbiol Immunol; 1990 Dec; 2(5-6):263-8. PubMed ID: 2127368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic control of delayed type hypersensitivity to Mycobacterium leprae antigen.
    Ishii N; Nakajima H; Aoki I; Shimoda N; Mori T
    Nihon Rai Gakkai Zasshi; 1990; 59(3-4):154-61. PubMed ID: 2133466
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The first clinical trial of immuno's experimental Pseudomonas aeruginosa flagellar vaccines.
    Crowe BA; Enzersberger O; Schober-Bendixen S; Mitterer A; Mundt W; Livey I; Pabst H; Kaeser R; Eibl M; Eibl J
    Antibiot Chemother (1971); 1991; 44():143-56. PubMed ID: 1801633
    [No Abstract]   [Full Text] [Related]  

  • 59. Induction by killed Listeria monocytogenes of effector T cells mediating delayed-type hypersensitivity but not protection in mice.
    Koga T; Mitsuyama M; Handa T; Yayama T; Muramori K; Nomoto K
    Immunology; 1987 Oct; 62(2):241-8. PubMed ID: 2445666
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response.
    Hoiby N
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):551-8. PubMed ID: 4213330
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.